Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 8Active not recruiting 5Withdrawn 3Terminated 3Recruiting 3Unknown 2Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Small Cell Lung Carcinoma 3Cholangiocarcinoma 3Lung Neoplasms 2Liver Neoplasms 2Carcinoma, Hepatocellular 2Urinary Bladder Neoplasms 1Respiratory Tract Neoplasms 1Rare Tumour 1Pancreatic Neoplasms 1Pancoast Syndrome 1Ovarian Neoplasms 1Gallbladder Neoplasms 1Biliary Tract Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 21130-nm albumin-bound paclitaxel 8irinotecan sucrosofate 7Oxaliplatin 7Leucovorin 7Fluorouracil 7Taxes 5Drug Therapy 5Albumin-Bound Paclitaxel 4toripalimab 3Specimen Handling 3S 1 (combination) 3Paclitaxel 3Irinotecan 3Injections 3zimberelimab 2surufatinib 2camrelizumab 2Pemetrexed 2Pancreaticoduodenectomy 2Magnetic Resonance Spectroscopy 2Exercise 2Capecitabine 2Blood Specimen Collection 2Biopsy 2trastuzumab deruxtecan 1sintilimab 1semaglutide 1potassium oxonate 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Pancreatic Neoplasms × durvalumab × Clear all
NCT07619313 2026-06-04

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

Jonsson Comprehensive Cancer Center

Phase 1 Not yet recruiting
46 enrolled
Gastrointestinal

Pancreatic Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡